Please wait
0001808158PREM14AEX-FILING FEESSC 14AN/A 0001808158 2025-12-01 2025-12-01 0001808158 1 2025-12-01 2025-12-01 iso4217:USD xbrli:pure
Exhibit 107
CALCULATION
OF
FILING
FEE TABLES
Schedule 14A
(Form Type)
Repare Therapeutics Inc.
(
Exact Name
of Registrant as Specified in its Charter)
Table 1: Transaction Valuation
 
       
    
Proposed Maximum Aggregate
Value
of Transaction
 
Fee Rate
 
Amount of Filing
Fee
       
Fees to be Paid
  $81,913,022.10
(1)
  0.00013810   $11,312.19
(2)
       
Total Transaction Valuation
  $81,913,022.10
(1)
   
 
       
Total Fees Due for Filing
      $11,312.19
       
Total Fees Previously Paid
      $0
       
Total Fee Offsets
      $0
       
Net Fee Due
 
 
 
 
  $11,312.19
 
(1)
The transaction valuation is estimated solely for purposes of calculating the filing fee only. The transaction valuation was estimated by multiplying: (A) 45,007,155 common shares, no par value, of the Registrant entitled to receive consideration in the transaction, consisting of the sum of (i) 43,108,362 issued and outstanding common shares, (ii) 227,255 common shares subject to RSU awards and (iii) 1,671,538 common shares subject to in-the-money Options; and (B) $1.82, being the total consideration expected to be paid per Share in the transaction (including the estimated value of any
non-cash
consideration).
(2)
The amount of the filing fee was calculated in accordance with Rule
0-11
under the Securities Exchange Act of 1934, as amended, and Fee Rate Advisory #1 for Fiscal Year 2026, effective October 1, 2025, by multiplying the transaction value by 0.00013810 (which equals a fee of $138.10 for each $1,000,000 of the aggregate amount of the transaction valuation.